Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propylene glycol + polyethylene glycol is a combination topical lubricant (artificial tear) formulation used for the treatment of dry eye disease. It acts as a demulcent by increasing the volume of the tear film and forming a protective gel matrix on the ocular surface. This matrix helps reduce tear evaporation and drainage, maintaining moisture and protecting the corneal epithelium. A specific preservative-free formulation, Glicolub Ultra (0.3% propylene glycol and 0.4% polyethylene glycol 400), developed by Tecnoquimicas, is used to manage mild to moderate dry eye symptoms. The combination is also widely known under the brand name Systane, developed by Alcon.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propylene glycol + polyethylene glycol.